|
|||||
       |
(National Institute on Aging, NIH) The Gladstone Institutes in San Francisco, California and the pharmaceutical company H. Lundbeck A/S of Copenhagen, Denmark have agreed to study and identify therapeutic candidates for neurological diseases. The agreement funds research at the Gladstone Center for Translational Research led by Gladstone investigator Katerina Akassoglou, and establishes the . . . → Read More: Partnership to Identify Targets for Neurological Diseases Cyclone Power Technologies Inc. of Pompano Beach, Florida reports it has performed combustion acceptability tests of crude oil recovered from the BP oil spill in the Gulf of Mexico with its heat-regenerative external combustion engine. The Cyclone engine burns its fuel in an external combustion chamber, with heat from this process used to turn water . . . → Read More: External Combusion Engine Tests Burning Oil from BP Spill A partnership between the Celebration Stem Cell Centre and Mercy Gilbert Medical Center — both in Gilbert, Arizona — has created a facility for cord blood stem cell research, processing, and storage. Gilbert is about 17 miles southeast of Phoenix. Mercy Gilbert Medical Center, with several other Phoenix-area hospitals, and hospitals in the Catholic Healthcare . . . → Read More: Cord Blood Stem Cell Research Center Opens in Arizona Solar cells in transparent plastic (New Energy Technologies Inc.) Researchers at New Energy Technologies Inc. of Burtonsville, Maryland report achieving scientific and technical breakthroughs allowing completion in the upcoming weeks of a working prototype of the world’s first glass window capable of generating electricity. Current solar energy systems use opaque panels. The ability . . . → Read More: Window Glass Solar Power Prototype in Development To meet an expanding demand for autonomous power for wireless sensors, MicroGen Systems LLC, of Ithaca, New York and Cornell University’s Energy Materials Center (emc2) have agreed to develop self-charging batteries that use background vibrations for their energy source. The battery, say the partners, will look like a microchip, but with a vibrating core, which . . . → Read More: Cornell, Nanotech Company to Develop Self-Charging Batteries Solazyme Inc. in South San Francisco, California has delivered 1,500 gallons of 100 percent algae-based jet fuel for the U.S. Navy’s testing and certification program. The delivery fulfills a contract awarded to Solazyme in September 2009. The Navy previously announced its objective to operate at least 50 percent of its fleet on renewable fuel by . . . → Read More: Biotech Company Delivers Algae-based Jet Fuel to U.S. Navy The European Commission (EC) announced today nearly €6.4 billion of investment in research and innovation. The funding, its largest to date, covers a vast range of scientific disciplines and commercial sectors, with a special emphasis on smaller businesses. The EC says this funding will increase European competitiveness and address critical policy issues, with some €800 . . . → Read More: Research Funding Boosted in Europe, Targets Small Business A cosmetics and personal care products trade group on Friday called for the U.S. Food and Drug Administration (FDA) to play a larger role in assessing the safety of ingredients used in their products. The Personal Care Products Council says it favors establishment of formal processes for FDA to review ingredients for safety at the . . . → Read More: Cosmetics Group Calls for More FDA Oversight of Ingredients Industrial Nanotech Inc., a maker of energy-saving products based on nanotechnology in Naples, Florida, reported today development of thermal insulation coating that can work on surfaces of at least 1,000 degrees Fahrenheit. The nanotech-based product called Nansulate Extreme High Heat was made from a request by the Saudi European Petrochemical Company, Ibn Zahr, to insulate . . . → Read More: Nanotech Material Insulates Saudi Pipeline Adolor Corporation, a drug discovery and development company in Exton, Pennsylvania will reduce its staff by 30 percent to meet an expected cash flow reduction over the next two years. The company specializes in pharmaceuticals for pain management. In its press release, Adolor says sales of its flagship product Entereg, developed for upper and lower . . . → Read More: Drug Discovery Company Cutting 30% of Staff |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.